Barrington Research restated their hold rating on shares of HealthStream (NASDAQ:HSTM) in a research note released on Tuesday. Barrington Research also issued estimates for HealthStream’s FY2018 earnings at $0.38 EPS, Q1 2019 earnings at $0.09 EPS, Q2 2019 earnings at $0.10 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.12 EPS and FY2019 earnings at $0.43 EPS.
“We believe the timing of the product introduction is very important as the company’s current agreement with Laerdal, its current partner, expires at the end of 2018. The company added a fourth partner to its resuscitation venture in Q3/18.”,” the firm’s analyst commented.
Other equities research analysts have also recently issued reports about the stock. TheStreet upgraded shares of HealthStream from a c+ rating to a b- rating in a research report on Thursday, August 9th. Zacks Investment Research upgraded shares of HealthStream from a hold rating to a buy rating and set a $31.00 price target on the stock in a research report on Thursday, July 26th. BidaskClub upgraded shares of HealthStream from a hold rating to a buy rating in a research report on Friday, August 24th. ValuEngine upgraded shares of HealthStream from a hold rating to a buy rating in a research report on Tuesday, July 10th. Finally, Canaccord Genuity reiterated a hold rating and issued a $26.00 price target on shares of HealthStream in a research report on Monday, July 23rd. Seven research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of Hold and an average price target of $27.40.
HealthStream (NASDAQ:HSTM) last issued its quarterly earnings results on Monday, October 22nd. The technology company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.08 by $0.03. HealthStream had a net margin of 14.23% and a return on equity of 4.03%. The firm had revenue of $59.93 million for the quarter, compared to analysts’ expectations of $58.22 million. During the same period in the previous year, the business earned $0.08 earnings per share. HealthStream’s revenue for the quarter was up 9.5% compared to the same quarter last year. Equities research analysts anticipate that HealthStream will post 0.36 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Piedmont Investment Advisors LLC acquired a new stake in HealthStream during the 2nd quarter worth about $165,000. BB&T Corp acquired a new stake in HealthStream during the 3rd quarter worth about $205,000. SG Americas Securities LLC acquired a new stake in HealthStream during the 2nd quarter worth about $213,000. Barclays PLC raised its holdings in HealthStream by 45.6% during the 1st quarter. Barclays PLC now owns 9,444 shares of the technology company’s stock worth $235,000 after buying an additional 2,958 shares during the period. Finally, Macquarie Group Ltd. acquired a new stake in HealthStream during the 2nd quarter worth about $322,000. Hedge funds and other institutional investors own 71.99% of the company’s stock.
HealthStream Company Profile
HealthStream, Inc provides workforce and provider solutions to the healthcare organizations in the United States. It operates in HealthStream Workforce Solutions and HealthStream Provider Solutions segments. The company offers workforce development solutions comprising software-as-a-service (SaaS) and subscription-based products to meet talent management, training, certification, competency assessment, performance appraisal, and development needs, as well as training, implementation, and account management services.
Read More: Ex-Dividend
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.